-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Enanta Pharmaceuticals Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2011 to 2025.
- Enanta Pharmaceuticals Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending December 31, 2024 was -$4.99M, a 32.2% increase year-over-year.
- Enanta Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2025 was -$26.6M, a 3.65% increase from 2024.
- Enanta Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$27.6M, a 114% decline from 2023.
- Enanta Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $198M, a 889% increase from 2022.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)